ACAAI Network Search

After a three-year hiatus, your Advocacy Council Strike Force has resumed in-person advocacy. Last week, the following College leaders visited Washington, DC, to meet with congressional leaders and policymakers to advocate for issues important to practicing allergists: Michael Blaiss, MD, FACAAI, executive…

The FDA granted emergency use authorization of a breath test that can detect COVID-19 infections within as little as three minutes and has a 0.7% rate of false positives. During COVID-19 the rate of children receiving routine immunizations including the measles…

It’s Food Allergy Awareness Week! More than 32 million Americans have a serious and potentially life-threatening food allergy, and many College members see patients with this condition. The College has food allergy resources for our members. From toolkits to webinars, enhance your…

May is National Asthma and Allergy Awareness Month! It’s a great time to promote your special training as an allergist – and the College has just what you need. Also take time this month to explore the College’s member resources to help you…

Claims for drugs/biologics should be billed using the HCPCS/CPT code that most accurately describes the drug. Information in this article concerns drug administration services provided in physicians’ offices. Under the Medicare program, the administration of the following drugs should be billed using…

Last month, William Husel, MD, was acquitted on all counts related to deaths from prescribing fentanyl in high doses to 14 terminally ill patients in one of the largest murder trials in the state of Ohio. It was noted that he prescribed doses for…

A statistical analysis of reported cases, hospital admissions, reported deaths, and seroprevalence estimates that 43.9% of the global population had been infected with SARS-CoV-2 at least once as of Nov 14, 2021. Nationwide, 86% of COVID cases in the week ending…

The specialty’s leading advocate, the Advocacy Council, is committed to bringing you news and insights on billing, coding and policy reform that directly affect your practice. Advocacy Insider, a recurring column in College Insider, keeps you in the loop. Contact us at AdvocacyCouncil…

The CMS National Standards Group (NSG) published guidance clarifying that health plans, as well as their payment vendors, must provide payments to providers using standardized electronic fund transfers (EFT) and electronic remittance advice (ERA) transactions without charging excessive fees. For many years, health plans…

We’d like to thank all of you who took the time to participate in our recent membership survey. Your feedback will help us ensure we’re providing the programming and resources you need. The following ten lucky members were selected, at random, in…

Retaining great employees and keeping them motivated is one of the most important tasks for a successful allergy practice – and it may require extra effort in the current environment. Many allergy practice employees are feeling burned out due to staffing shortages and increased…

The Department of Health and Human Services (HHS) opened the application for Phase 4 COVID-19 Provider Relief Funding. National Institute of Allergy and Infectious Diseases (NIAID) Director Dr. Anthony Fauci announced that the National Institutes of Health (NIH) will soon release data regarding…

A new study shows surgical masks are more effective than cloth masks in preventing infections from the Delta variant. A new Centers for Disease Control and Prevention (CDC) study shows how the three FDA-authorized COVID-19 vaccines remain effective at preventing hospitalization over…

Moderna officially asked the Food and Drug Administration (FDA) to authorize a third “booster” dose of its COVID-19 vaccine. Meanwhile, Moderna and Pfizer released data illustrating that a vaccine booster shot is necessary because the effectiveness of their vaccines decline over time. Pfizer…

The Medicare Payment Advisory Commission (MedPAC) is considering the recommendation of a one-time Medicare payment increase in 2023 to help offset the financial impact COVID-19 had on healthcare providers. The COVID-19 booster dose rollout will only include the Pfizer vaccine when…

Moderna filed for FDA authorization of a third-dose booster shot of its COVID-19 vaccine; and a recent study found that the Moderna vaccine produces more antibodies than the Pfizer/BioNTech vaccine. A study in Israel showed the COVID-19 booster shot effectively…

National Institutes of Health (NIH) Director Francis Collins said we have not yet reached a peak as delta variant cases continue to increase. The Centers for Medicare and Medicaid Services (CMS) announced it will cover the newly approved third COVID-19 vaccine dose for…

The Delta variant accounts for 93% of cases in the U.S. The National Institute of Allergy and Infectious Diseases (NIAID) Director Dr. Anthony Fauci warned about the possible emergence of new variants. Moderna also believes regular booster shots will be necessary to maintain…